FORUM annual lecture

The Academy’s FORUM annual lecture recognises a key individual working at the interface of academia, industry and healthcare and provides an opportunity to promote discussion amongst FORUM members, Academy Fellows and invited guests.

2018 -Transforming healthcare through engineering and technology

Dr Omar Ishrak, Chair and Chief Executive Officer, Medtronic

Panel participants:

  • Professor Alison Noble OBE FRS FREng, Professor of Biomedical Engineering, University of Oxford
  • Professor Sebastien Ourselin, Head of the School of Biomedical Engineering & Imaging Sciences, King's College London
  • Professor Lionel Tarassenko CBE FREng FMedSci, Chair in Electrical Engineering, University of Oxford
  • Professor Chris Taylor OBE FREng, Professor of Medical Biophysics and Professor of Computer Science, University of Manchester

2017 - The mind-body interface
Professor Kevin Tracey, President and CEO, The Feinstein Institute for Medical Research

Panel participants:

  • Professor Ed Bullmore, Head of Department of Psychiatry, University of Cambridge
  • Professor Matthew Hotopf, Professor General Hospital Psychiatry, King's College London
  • Professor Brenda Penninx, Professor of Psychiatric Epidemiology, EMGO Institute for Health and Care Research, VU University Medical Center Amsterdam
  • Melissa Smith, Ophthalmology nurse and service user, East Sussex Healthcare NHS Trust

 2016 - What can research do to improve productivity in the NHS?
Dame Julie Moore, Chief Executive, University Hospitals Birmingham NHS Foundation Trust

Panel participants:

  • Dr Annette Doherty OBE, Senior Vice President of Product Development, GlaxoSmithKline
  • Dr Nicolaus Henke, Director of Healthcare Systems and Services Practice, McKinsey & Company
  • Rt Hon Stephen Dorrell, Chair, NHS Confederation and Senior Adviser, KPMG
  • Professor Sir Simon Wessely FMedSci, Chair of Psychological Medicine, King's College London and President, Royal College of Psychiatrists

2015 - A vision for the life sciences sector
Mr George Freeman MP, Parliamentary Under Secretary of State for Life Sciences

Panel participants:
  • Professor Sir John Bell GBE FRS HonFREng FMedSci, Regius Professor of Medicine, University of Oxford
  • Mr Chris Brinsmead CBE, Life Sciences Business Adviser
  • Mr John Jeans CBE, Chairman of Imanova, Chair of Cardiff University, Chair of UK Biocentre

2014 - Horizon scanning: looking ahead to 2025

  • Sir Gordon Duff, Chairman, Medicines and Healthcare Products Regulatory Agency
  • Professor Sir Malcolm Grant, Chair, NHS England
  • Professor Dame Nancy Rothwell, President and Vice- Chancellor, University of Manchester
  • Professor Patrick Vallance, President, Pharmaceuticals R&D, GSK

2013The changing pharmaceutical industry and the opportunity for precision medicine
Dr Ruth McKernan, Senior Vice President at Pfizer and Chief Scientific Officer at Neusentis

2012 - Frameworks of the Regulation of Medicinal Products: Opportunities and Challenges
Sir Alasdair Breckenridge CBE FRSE FMedSci, Chairman, MHRA

2011 - China's recent transformation into a major centre of medical research and innovation
Dr Jingwu Zang, Senior Vice President and Head of R&D China, GlaxoSmithKline

2010 - The importance of regulatory science to the healthcare portfolio
Dr Margaret Hamburg, Commissioner, Food and Drug Administration

2009 - UK life sciences - ensuring a healthy future
Lord Drayson of Kensington, Minister of State for Science & Innovation

2008 - The UK pharmaceutical industry - what does the future hold?
Andrew Witty, CEO Designate, GlaxoSmithKline

2007 - The highs and lows of academic-industrial collaborations
Professor Dame Nancy Rothwell FRS FMedSci

2006 - The human genome - realising the pharmaceutical opportunities
Dr Tim Rolph, Head of Discovery, Sandwich Laboratories, Pfizer Global R&D

2005 - Cancer research in the UK - areas of optimism & concern
Professor Alex Markham FMedSci, Chief Executive, Cancer Research UK

2004 - Can Europe compete in biomedical research?
Sir Tom McKillop, Chief Executive, AstraZeneca

2003 - Pharmacogenetics and personalised medicine
Dr Allen Roses, Senior Vice President, Genetics Research & Development, GlaxoSmithKline, North Carolina
 

Staff leads


Labour party conference 2018

Book Now

Conservative party conference 2018

Book Now

2018 The Academy of Medical Sciences and The Lancet International Health Lecture

Book Now
View more
 
 
 
 
 
 
FB Twitter Instagram Youtube